Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses

Abstract

Two established activities of the multifunctional human hepatitis B virus X-protein are its transactivating and pro-apoptotic potential. We analysed whether X-proteins from other orthohepadnaviruses and the newly discovered avihepadnaviral X-proteins have similar functions as HBx. Previously, we have shown that HBx suppresses oncogenic transformation of primary rat embryo fibroblasts (REF) by induction of apoptosis. Using this system, we found that the wildtype X-proteins of woodchuck, ground squirrel, arctic squirrel and woolly monkey hepatitis B virus exhibit similar levels of pro-apoptotic activity as HBx, whereas mutants with carboxyterminal deletions were severely impaired in this activity. A strong correlation between the pro-apoptotic and transactivating abilities of the mammalian X-proteins was found. The newly discovered avihepadnaviral X-like proteins showed similar and Raf-MAPK pathway-dependent transactivating abilities and induced apoptosis in the REF-assay. Our data indicate that the transactivating and pro-apoptotic activities reside in the carboxyterminal half of orthohepadnaviral X and are conserved in avihepadnaviral X-proteins.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Andrisani OM, Barnabas S . 1999 Int. J. Oncol. 15: 373–379

  • Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K . (eds). 1998 Current Protocols in Molecular Biology New York: John Wiley & Sons, Inc. pp 974–976

    Google Scholar 

  • Beasley RP, Hwang LY, Lin CC, Chien CS . 1981 Lancet 2: 1129–1133

  • Becker SA, Lee TH, Butel JS, Slagle BL . 1998 J. Virol. 72: 266–272

  • Bergametti F, Prigent S, Luber B, Benoit A, Tiollais P, Sarasin A, Transy C . 1999 Oncogene 18: 2860–2871

  • Bouchard MJ, Wang LH, Schneider RJ . 2001 Science 294: 2376–2378

  • Buendia MA, Paterlini P, Tiollais P, Bréchot C . 1998 Viral hepatitis. 2nd. edn. Vol.?: Zuckerman AJ and Thomas CT (eds) London: Churchill Livingstone pp. 179–200

    Google Scholar 

  • Chang SF, Netter HJ, Bruns M, Schneider R, Frölich K, Will H . 1999 Virology 262: 39–54

  • Chang SF, Netter HJ, Hildt E, Schuster R, Schaefer S, Hsu YC, Rang A, Will H . 2001 J. Virol. 75: 161–170

  • Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH . 1993 J. Virol. 67: 1218–1226

  • Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, Levrero M . 1997 Proc. Natl. Acad. Sci. USA 94: 8162–8167

  • Colgrove R, Simon G, Ganem D . 1989 J. Virol. 63: 4019–4026

  • Cuende E, Ales-Martinez JE, Liyun D, Gonzalez-Garcia M, Martinez-A C, Nunez G . 1993 EMBO J. 12: 1555–1560

  • Dane DS, Cameron CH, Briggs M . 1970 Lancet 1: 695–698

  • Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD . 2001 J. Biol. Chem. 276: 8328–8340

  • Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC . 1997 Proc. Natl. Acad. Sci. USA 94: 14707–14712

  • Feitelson MA, Miller RH . 1988 Proc. Natl. Acad. Sci. USA 85: 6162–6166

  • Gottlob K, Fulco M, Levrero M, Graessmann A . 1998a J. Biol. Chem. 273: 33347–33353

  • Gottlob K, Pagano S, Levrero M, Graessmann A . 1998b Cancer Res. 58: 3566–3570

  • Grethe S, Heckel JO, Rietschel W, Hufert FT . 2000 J. Virol. 74: 5377–5381

  • Hu X, Margolis HS, Purcell RH, Ebert J, Robertson BH . 2000 Proc. Natl. Acad. Sci. USA 97: 1661–1664

  • Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC . 2001 Oncogene 20: 3620–3628

  • Kim CM, Koike K, Saito I, Miyamura T, Jay G . 1991 Nature 351: 317–320

  • Kim H, Lee H, Yun Y . 1998 J. Biol. Chem. 273: 381–385

  • Kim YC, Song KS, Yoon G, Nam MJ, Ryu WS . 2001 Oncogene 20: 16–23

  • Land H . 1995 Meth. Enzym. 254: 37–41

  • Land H, Parada LF, Weinberg RA . 1983 Nature 304: 596–602

  • Lanford RE, Chavez D, Brasky KM, Burns III RB, Rico Hesse R . 1998 Proc. Natl. Acad. Sci. USA 95: 5757–5761

  • Lanford RE, Chavez D, Rico-Hesse R, Mootnick A . 2000 J. Virol. 74: 2955–2959

  • Lee TH, Elledge SJ, Butel JS . 1995 J. Virol. 69: 1107–1114

  • Lin B, Anderson DA . 2000 Intervirology 43: 185–190

  • MacDonald DM, Holmes EC, Lewis JC, Simmonds P . 2000 J. Virol. 74: 4253–4257

  • Marion PL, Knight SS, Ho BK, Guo YY, Robinson WS, Popper H . 1984 Proc. Natl. Acad. Sci. USA 81: 898–902

  • Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS . 1980 Proc. Natl. Acad. Sci. USA 77: 2941–2945

  • Marion PL, Van Davelaar MJ, Knight SS, Salazar FH, Garcia G, Popper H, Robinson WS . 1986 Proc. Natl. Acad. Sci. USA 83: 4543–4546

  • Mason WS, Seal G, Summers J . 1980 J. Virol. 36: 829–836

  • Murakami S . 1999 Intervirology 42: 81–99

  • Netter HJ, Chassot S, Chang SF, Cova L, Will H . 1997 J. Gen. Virol. 78: 1707–1718

  • Norder H, Ebert JW, Fields HA, Mushahwar IK, Magnius LO . 1996 Virology 218: 214–223

  • Oguey D, Dumenco LL, Pierce RH, Fausto N . 1996 Hepatology 24: 1024–1033

  • Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL . 1987 Proc. Natl. Acad. Sci. USA 84: 866–870

  • Poussin K, Dienes H, Sirma H, Urban S, Beaugrand M, Franco D, Schirmacher P, Bréchot C, Paterlini Bréchot P . 1999 Int. J. Cancer 80: 497–505

  • Pult I, Netter HJ, Bruns M, Prassolov A, Sirma H, Hohenberg H, Chang SF, Frölich K, Krone O, Kaleta EF, Will H . 2001 Virology 289: 114–128

  • Runkel L, Fischer M, Schaller H . 1993 Virology 197: 529–536

  • Schuster R, Gerlich WH, Schaefer S . 2000 Oncogene 19: 1173–1180

  • Seeger C, Ganem D, Varmus HE . 1984 J. Virol. 51: 367–375

  • Seifer M, Höhne M, Schaefer S, Gerlich WH . 1991 Viral Hepatitis-1990. Hollinger F, Lemon S and Margolis H (eds) New York: Williams and Wilkins pp. 586–588

    Google Scholar 

  • Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL . 2000 J. Biol. Chem. 275: 25858–25864

  • Shintani Y, Yotsuyanagi H, Moriya K, Fujie H, Tsutsumi T, Kanegae Y, Kimura S, Saito I, Koike K . 1999 J. Gen. Virol. 80: 3257–3265

  • Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M, Koike K . 1989 Jpn. J. Cancer Res. 80: 617–621

  • Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Bréchot C . 1999 Oncogene 18: 4848–4859

  • Sitterlin D, Bergametti F, Tiollais P, Tennant BC, Transy C . 2000a Oncogene 19: 4427–4431

  • Sitterlin D, Bergametti F, Transy C . 2000b Oncogene 19: 4417–4426

  • Sitterlin D, Lee TH, Prigent S, Tiollais P, Butel JS, Transy C . 1997 J. Virol. 71: 6194–6199

  • Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS . 1996 Mol. Carcinog 15: 261–269

  • Sprengel R, Kaleta EF, Will H . 1988 J. Virol. 62: 3832–3839

  • Su F, Schneider RJ . 1997 Proc. Natl. Acad. Sci. USA. 94: 8744–8749

  • Summers J, Smolec JM, Snyder R . 1978 Proc. Natl. Acad. Sci. USA. 75: 4533–4537

  • Takada S, Shirakata Y, Kaneniwa N, Koike K . 1999 Oncogene 18: 6965–6973

  • Takahashi K, Brotman B, Usuda S, Mishiro S, Prince AM . 2000 Virology 267: 58–64

  • Terradillos O, Billet O . 1997 Oncogene 14: 395–404

  • Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA . 1998 Oncogene 17: 2115–2123

  • Testut P, Renard CA, Terradillos O, Vitvitski Trepo L, Tekaia F, Degott C, Blake J, Boyer B, Buendia MA . 1996 J. Virol. 70: 4210–4219

  • Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Brechot P, Brechot C, Kremsdorf D . 2001 Cancer Res. 61: 7803–7810

  • Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher HW, Hoeijmakers JH, Harris CC . 1995 Cancer Res. 55: 6012–6016

  • Warren KS, Heeney JL, Swan RA, Heriyanto, Verschoor EJ . 1999 J. Virol. 73: 7860–7865

  • White E, Cipriani R, Sabbatini P, Denton A . 1991 J. Virol. 65: 2968–2978

  • Yu DY, Moon HB, Son JK, Jeong S, Yu SL, Yoon H, Han YM, Lee CS, Park JS, Lee CH, Hyun BH, Murakami S, Lee KK . 1999 J. Hepatol 31: 123–132

  • Zoulim F, Saputelli J, Seeger C . 1994 J. Virol. 68: 2026–2030

Download references

Acknowledgements

We thank B Luber (c-Ha-ras and c-myc), CW Distelhorst (Bcl-2) and E White (E1B) for providing the indicated constructs.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephan Schaefer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schuster, R., Hildt, E., Chang, SF. et al. Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. Oncogene 21, 6606–6613 (2002). https://doi.org/10.1038/sj.onc.1205916

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205916

Keywords

This article is cited by

Search

Quick links